Valneva SE (VALN) Other Operating Expenses (2021 - 2026)
Valneva SE's (VALN) quarterly Other Operating Expenses came in at $2.3 million in Q1 2026, little changed year-on-year from $2.3 million in Q1 2025, and down 81.3% quarter-over-quarter from $12.1 million in Q4 2025.
Valneva SE (VALN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Other Operating Expenses across 6 years of filings, most recently posting $2.3 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $2.3 million, changed 0.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (down 49.55% YoY), and the FY2025 annual result was $12.1 million, down 45.29% from the prior year.
- Other Operating Expenses came in at $2.3 million for Q1 2026 at Valneva SE, down from $12.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $116.1 million in Q3 2024 to a low of -$101.0 million in Q2 2024.
- The 5-year median for Other Operating Expenses is $3.5 million (2024), against an average of $4.7 million.
- Peak annual rise in Other Operating Expenses reached 861.03% in 2024, while the deepest fall reached 980.72% in 2024.
- Valneva SE's Other Operating Expenses stood at $4.8 million in 2022, then soared by 380.11% to $23.2 million in 2023, then sank by 73.16% to $6.2 million in 2024, then surged by 94.79% to $12.1 million in 2025, then slumped by 81.3% to $2.3 million in 2026.
- The last three Other Operating Expenses figures came in at $2.3 million (Q1 2026), $12.1 million (Q4 2025), and -$2.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 12.11 Mn |
| Jun 30, 2025 | -2.45 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 116.11 Mn |
| Jun 30, 2024 | -100.96 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 23.15 Mn |
| Sep 30, 2023 | -15.26 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Mar 31, 2023 | 3.74 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 6.66 Mn |
| Jun 30, 2021 | 8.92 Mn |
| Mar 31, 2021 | 3.59 Mn |